Skip to main content
. 2022 Feb 8;19(3):1884. doi: 10.3390/ijerph19031884

Table 3.

Comparison of outcomes from pregnancies diagnosed with gestational diabetes (GDM) in 2019 (routine screening for GDM using a two-step approach with GCT and glucose tolerance test) and 2020 (modified screening for GDM due to the COVID-19 pandemic).

All GDM Positive 2019
n = 92
All GDM Positive 2020
n = 42
p-Value
BMI, mean( SD) 28.5 (5.6) 29.4 (6.6) 0.15
Age, mean (SD) 36 (4.9) 34.(5.7) 0.1
Gestational age at glucose Challenge test (weeks), mean (SD) 29 (4.1) 28 (5) 0.04
Booking weight, mean (SD) 74.7 (16) 74.7 (17.8) 0.52
Infant head circumference (cm), mean (SD) 64 (29.4) 61 (32) 0.37
Infant length (cm), mean (SD) 73.7 (26.3) 50 (31) 0.08
Birth weight (g), mean (SD) 3608 (481) 3488 (638) 0.44
Rate of postpartum Haemorrhage (PPH), n (%) 19 (20.7%) 5 (11.9%) 0.21
Birth weight > 90th centile, n (%) 17 (18.5%) 8 (19%) 0.96
Gestational age at birth (weeks), mean (SD) 39.6 (1.3) 39.3 (1.5) 0.06
Induction of labour, n (%) 31 (33.7%) 29 (47.6%) 0.06
Mode of birth, n (%)
Spontaneous vaginal birth 47(51.1%) 19 (45.2%) 0.7
Instrumental birth 13 (14.1%) 3 (7.1%) 0.8
Caesarean section 32 (34.8%) 20 (47.6%) 0.16
Initial treatment of GDM <0.01
Diet and exercise only 89 (96.7%) 31 (73.8%)
Metformin 1 (1.1%) 2 (4.8%)
Insulin 2 (2.2%) 9 (21.4%)
Term treatment <0.01
Diet and exercise alone 79 (86%) 21 (50%)
Metformin 7 (7.6%) 6 (14.3%)
Insulin 5 (5.4%) 13 (31%)

BMI: body mass index, GA: gestational age, GCT: glucose challenge test, GDM: gestational diabetes.